Collaborations
Overview
2023 DDI Collaborations
3
New Collaboration
11
Reviewed Collaborations
1
New Consortium
9
Ongoing Consortiums
International Collaborations
In 2023, DDI continued to expand its national, regional, and international network via enhancement of its national and international collaborations. Of the major existing collaborations 11 were reviewed and reassessed with 3 new collaborations concluded.
| International Research Collaborations | |||
| 1 | Montreal Diabetes Research Centre | 8 | BIDMC-Harvard |
| 2 | McGill University | 9 | World Health Organization |
| 3 | University of Glasgow | 10 | Yale University |
| 4 | Sunnybrook Research Institute | 11 | Oxford University |
| 5 | Onze Lieve Vrede Hospital | 12 | Université Paris Cité INSERM* |
| 6 | University of Texas Health Science Center | 13 | University of Ottawa* |
| 7 | Ulster University | 14 | Deakin University* |
Regional Collaborations
DDI continued to collaborate on multiple research projects with 3 major regional collaborators in 2023.
| Regional Institutions | |
| 1 | Weill Cornell University, Qatar |
| 2 | Hamad Medical Corporation – Qatar |
| 3 | King Abdullah University of Science and Technology |
National Collaborations
DDI continues to collaborate nationally to exchange knowledge to strengthen and contribute to the country’s scientific research community to enhance knowledge transfer and scientific capacity building with national institutes and ministries.
In 2023 DDI continued to collaborate with the Kuwait Ministry of Health (MOH) and Kuwait University (KU) on multiple projects covering various scientific disciplines. A breakdown of the number of projects is illustrated below with a total number of national projects with KU and MOH reaching 36 for 2023.
Consortiums
Consortiums provide multiorganizational groups the opportunity to coordinate, network and pull resources together for common well-defined scientific goals. To enhance joint alliances, DDI participated in 9 ongoing consortiums and 1 new consortium during 2023.
| International Consortiums | |
| 1 | Genetic Investigation of Anthropometric Traits (GIANT) |
| 2 | Global Lipids Genetics (GLGC) at Broad Institute (USA) |
| 3 | Weill-Cornell Medicine (Qatar and New York) on genome data sharing & integration |
| 4 | COVIDiaB Registry |
| 5 | NCD Risk Factor Collaboration (NCD-RisC) |
| 6 | COVID Human Genetic Efforts (MISC) – Rockefeller University |
| 7 | International SWEET Network |
| 8 | The Meta-Analysis of Glucose and Insulin-related traits Consortium (MAGIC) |
| 9 | Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients with Type 2 Diabetes Across Countries in the Middle East and Africa (PACT-MEA)* |
| 10 | DAFNE Consortium |
In addition to the above, DDI researchers are associated and work on multiple research projects with over 11 international institutions worldwide on a project level basis, over and above the ones listed above.
